In another study [39], Cediranib, a potent inhibitor of VEGFRs, which also targets KIT and PDGFRA, was shown to induce a significant reduction of U251 glioma cells in S phase and a higher percentage of apoptotic cells. Here, PDGFRA is linked to glioma.